Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2017-01-12
Summary
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment.
Conditions
- Opioid-Related Disorders
Interventions
- DRUG
-
Buprenorphine/naloxone
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Walter Ling, M.D. · Friends Research Institute, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2000-08-31
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
NCT00000329 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
NCT00000326 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
NCT00015028 ·Status: COMPLETED ·Phase: PHASE2
-
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
NCT01136356 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Buprenorphine Treatment for Opioid Dependence
NCT02187198 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000330 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine Maintenance for Opiate Dependence - 6
NCT00000357 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
NCT02294253 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Liquid vs. Tablet Buprenorphine - 6
NCT00000341 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
NCT00015340 ·Status: COMPLETED ·Phase: PHASE4
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Naltrexone-P1 A-Cocaine
NCT00733720 ·Status: COMPLETED ·Phase: PHASE1
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Buprenorphine/Naloxone Film Strips
NCT00640835 ·Status: COMPLETED ·Phase: PHASE2
-
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
NCT00007527 ·Status: COMPLETED ·Phase: PHASE4
-
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
NCT02032433 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Buprenorphine/Naloxone
NCT02882412 ·Status: UNKNOWN
-
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
NCT00078117 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
NCT03740243 ·Status: WITHDRAWN ·Phase: PHASE4